(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 13.57%
6.42% $ 1.990
Live Chart Being Loaded With Signals
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 1.27M |
Średni wolumen | 564 388 |
Kapitalizacja rynkowa | 102.37M |
EPS | $0 ( 2024-03-06 ) |
Następna data zysków | ( $-0.350 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.380 |
ATR14 | $0.00600 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-18 | Jalota Deepika | Buy | 225 095 | Employee Stock Option (right to buy) |
2024-01-18 | Jalota Deepika | Buy | 95 555 | Common Stock |
2024-01-18 | Carulli Michael | Buy | 204 630 | Employee Stock Option (right to buy) |
2024-01-18 | Carulli Michael | Buy | 82 220 | Common Stock |
2024-01-18 | Mack David Henry | Buy | 519 915 | Employee Stock Option (right to buy) |
INSIDER POWER |
---|
60.33 |
Last 97 transactions |
Buy: 3 540 873 | Sell: 1 925 887 |
Wolumen Korelacja
PMV Pharmaceuticals, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
FCBC | 0.942 |
HOL | 0.938 |
EVLO | 0.937 |
LGMK | 0.935 |
EQBK | 0.935 |
FIBK | 0.935 |
GRNA | 0.933 |
BHTG | 0.931 |
SLNG | 0.928 |
LYEL | 0.928 |
10 Najbardziej negatywne korelacje | |
---|---|
GVCI | -0.96 |
APTM | -0.958 |
SCRM | -0.956 |
DPCS | -0.956 |
CCTS | -0.955 |
ORIA | -0.954 |
TIOA | -0.954 |
XPAX | -0.953 |
ARRW | -0.951 |
FRONU | -0.951 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PMV Pharmaceuticals, Inc. Korelacja - Waluta/Towar
PMV Pharmaceuticals, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.26M (0.00 %) |
EPS: | $-1.440 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.26M (0.00 %) |
EPS: | $-1.440 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-650 000 (0.00 %) |
EPS: | $-1.610 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.277 |
Financial Reports:
No articles found.
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej